Overview
- On December 9, H.C. Wainwright’s Gus Richard lifted Astera Labs’ price target to $195 and reiterated a Buy, citing expanding revenue per rack and hyperscaler demand.
- Recent coverage describes the stock as a potential buying opportunity following a roughly 40% pullback.
- Astera Labs reported Q3 revenue up 104% year over year to $230.6 million with non-GAAP EPS of $0.49, and Q4 guidance was characterized as above Street estimates.
- Analysts highlight a multi-product roadmap and partnerships targeting rack-level AI data centers, with Scorpio X scaling projected in 2H 2026 and NVLink Fusion expected to contribute in 2027.
- Commentary flags risks from elevated valuation, competition, and customer concentration, with investors watching upcoming updates on Scorpio X and UALink.